Evolem has acquired Apperton, a French leader in medical device sterilization services, for an undisclosed amount. This corporate acquisition sees Evolem taking full ownership of Apperton, an essential link in the national healthcare chain. Apperton provides critical sterilization prestations for hospitals, clinics, and laboratories, building on 30 years of cumulative experience since its formation in 2019 from the merger of Stérience and Vanguard.
Apperton specializes in offering tailored solutions designed to improve sterilization performance across economic, regulatory, and logistic domains. Its comprehensive multi-service portfolio includes in situ, ex situ, low-temperature sterilization, as well as back-up and delestage services, traceability solutions, and professional training. With 13 operational centers across France and one in Spain, supported by 370 collaborators and serving over 80 clients, Apperton maintains a strong regional presence and a reputation for adaptability and rigor in a highly demanding field.
The acquisition by Evolem is strategically aimed at reinforcing a crucial segment of the healthcare infrastructure. Apperton’s established market leadership and its vital role in ensuring the safety and performance of medical devices align with an investment in essential services. Evolem’s integration of Apperton is expected to facilitate continued investment in Apperton’s robust network and specialized capabilities, further enhancing its ability to provide uninterrupted, high-quality sterilization solutions.
Looking forward, the combined entity is poised to strengthen Apperton’s position as a national leader. This partnership is anticipated to drive further operational efficiencies and expand the reach of Apperton’s critical services, ensuring even greater proximity and responsiveness for healthcare establishments. The focus remains on innovation in sterilization techniques and maintaining stringent compliance standards, thereby contributing significantly to public health safety and operational resilience within the medical sector.